64 results
Page 3 of 4
10-K
pgavjzzc87wr
16 Mar 20
Annual report
11:09am
8-K
EX-99.1
f8a294sc ynyk3qf2
11 Mar 20
Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results
4:05pm
DEF 14A
ghp5g
1 Oct 19
Definitive proxy
6:07am
8-K
EX-99.1
l009hz16yl hr
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
alubzss qjtz4
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
EX-99.1
v5a4gs1myu
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-99.1
74ckrx01992
15 Aug 19
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
8:09am
8-K
EX-99.1
otgnefk
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
fotfp3
5 Aug 19
Prospectus supplement for primary offering
9:08am
8-K
EX-99.1
54ip8jc
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
424B5
aiz hgcpdc
2 Aug 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-99.1
h9lnkm6w67xd jwo5ywh
1 Aug 19
Entry into a Material Definitive Agreement
12:35pm
8-K
tfxye rlvc
1 Aug 19
Entry into a Material Definitive Agreement
12:35pm
S-3
sp4dqqb8v3gsx6f
21 Jun 19
Shelf registration
5:29pm
S-8
EX-4.7
o6fd2wh8 70
21 Jun 19
Registration of securities for employees
5:04pm
8-K
EX-99.1
bm9nw 2vz
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K12B
vpagmql yccc554
14 Jun 19
Notification of registration of securities
5:10pm